As India positions itself to become a dominant global hub for science-led industrial innovation, bridging the structural divide between commercial manufacturing and academic research takes top priority. To address this imperative, the upcoming ChemPharma R&D Summit 2026 will host a crucial panel discussion titled "Bridging the Chasm: Enhancing Industry-Academia Co-development Partnerships."

The agenda of the Summit is available Here. One can register on the below given Link:

https://www.indianchemicalnews.com/chempharma_r_and_d_summit_2026//register.php

Jointly organised by Indian Chemical News and Indian Pharma Post, the two-day flagship summit is scheduled for October 27–28, 2026, at the Courtyard by Marriott Mumbai International Airport, Mumbai. The event centers on the theme of "Innovation, Digital Transformation, and Sustainability".

The strategic session will bring together an exceptional cohort of administrative heads, leading scientists, and top-tier industrial R&D chiefs to outline actionable co-development frameworks. The panel features: Prof. Aniruddha B. Pandit, Vice Chancellor, Institute of Chemical Technology (ICT), Mumbai; Dr. Amol A. Kulkarni, Chief Scientist & Head, Chemical Engineering & Process Development Division, CSIR-National Chemical Laboratory (CSIR-NCL); Dr. Anubhav Saxena, Chief - R&D Office, Pidilite Industries; Dr. Prashant Puri, Head - R&D, Deepak Fertilisers and Petrochemicals Corporation Ltd. (DFPCL), Prof. Bhalchandra Bhanage, Vice Chancellor, The Maharaja Sayajirao University of Baroda, Vadodara and Dr. Debabrata Rautaray, Sr. Vice President and Chief Product Development & Innovation Officer, DCM Shriram Chemicals Innovation Centre.

The high-level dialogue will be steered by distinguished moderator Dr. Sivaram Swaminathan, Professor Emeritus at the Indian Institute of Science Education and Research (IISER), Pune.

As compressing commercial timelines demand rapid transitions from laboratory concepts to market-ready products, traditional transactional models must evolve into deeply integrated collaborations. The speakers will dissect six core operational and systemic areas: Shared Risk-Reward IP Frameworks, Agile Timeline Realignment, Joint Infrastructure Co-Location, Translational Funding Mechanisms, Curriculum Modernisation and Sustainability-Driven Focus Areas.

By addressing these core execution pillars, the panel aims to move beyond isolated pilot projects toward sustainable, repeatable innovation pipelines. The dialogue will ultimately provide a definitive blueprint to elevate India's chemical and pharmaceutical sectors into self-reliant, globally competitive economic powerhouses.